Skip to main content
Clinical Trials/NCT05702892
NCT05702892
Completed
Not Applicable

Evaluation Of Biomarkers Associated With Bone Metabolism İn Patients With Different Periodontal Status

Necmettin Erbakan University1 site in 1 country60 target enrollmentNovember 5, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Periodontal Diseases
Sponsor
Necmettin Erbakan University
Enrollment
60
Locations
1
Primary Endpoint
Evaluation of bone metabolism biomarkers in different periodontal conditions
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study evaluates the levels of biomarkers associated with bone metabolism in patients with different periodontal conditions.

Detailed Description

Background: In this study, the levels of bone metabolism markers found in the saliva of individuals with different periodontal conditions were compared and the relationship of these markers with periodontal status was examined. Method: A total of 60 individuals, 20 with periodontitis (P), 20 with gingivitis (G), and 20 with periodontal healthy (S), were included in the study. Periodontal clinical parameters (plaque index, gingival index, bleeding on probing, clinical attachment level and probing pocket depth) and saliva samples were obtained from the individuals. Bone metabolism biomarker (necrotizing factor (TNF)-α, osteoprotegerin (OPG), nuclear factor kappa-β receptor activator ligand (RANKL) and sclerostin) levels in saliva samples were evaluated by enzyme-linked immunosorbent assay (ELISA).

Registry
clinicaltrials.gov
Start Date
November 5, 2020
End Date
November 5, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ummuhan Tekin Atay

master in science

Necmettin Erbakan University

Eligibility Criteria

Inclusion Criteria

  • 18-65 years old.
  • not having any systemic disease that may affect periodontal status
  • not smoking and alcohol use
  • volunteer to participate in the study

Exclusion Criteria

  • periapical pathologies;
  • resulting from orthodontics and occlusion extreme forces, including mechanical forces;
  • chronic high-dose steroid therapy;
  • radiation or immunosuppressive therapy;
  • pregnancy;
  • breastfeeding;
  • allergy or sensitivity to any medication.
  • Periodontal therapy or drug therapy for at least 6 months of study participants

Outcomes

Primary Outcomes

Evaluation of bone metabolism biomarkers in different periodontal conditions

Time Frame: baseline

The levels of bone metabolism markers in the saliva of individuals with different periodontal status were compared and the relationship of these markers with periodontal status was examined.

Secondary Outcomes

  • Probing pocket depth(baseline)
  • Plaque index(baseline)
  • Gingival index(baseline)

Study Sites (1)

Loading locations...

Similar Trials